Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis (ILODOSE)
This study has been terminated.
( sufficient number to reach the primary endpoint and as planned )
Study NCT00622687   Information provided by Charite University, Berlin, Germany
First Received: February 14, 2008   Last Updated: February 22, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Systemic Sclerosis
Additional conditions recognized in this trial
Scleroderma, Diffuse
Scleroderma, Systemic
Sclerosis
More general conditions related to this trial
Connective Tissue Diseases
Pathologic Processes
Skin Diseases
Interventions listed in this trial
iloprost
iloprost low dose
More general drug interventions related to this trial
Cardiovascular Agents
Hematologic Agents
Pharmacologic Actions
Platelet Aggregation Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Charite University, Berlin, Germany
Schering-Plough


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services